Balanced news tone
News Sentiment
DHR sentiment intelligence
Danaher Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+0.6% over one week, +10.7% over four weeks, trend inactive, and near fair-value range.
The Zacks Analyst Blog Highlights Interactive Brokers, Danaher, S&P Global and Optical Cable
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
The Zacks Analyst Blog Highlights Interactive Brokers, Danaher, S&P Global and Optical Cable
This Zacks Analyst Blog highlights research reports on Interactive Brokers, Danaher, S&P Global, and Optical Cable, detailing their recent performance, growth drivers, and challenges. Interactive Brokers benefits from its broad offerings and conservative balance sheet, while Dana
- Tone
- Negative 40/100
- Event
- Analyst action
- Published
- 17 Jul 2026 13:07
- Source
- Market source
Danaher (DHR) Is Expanding Diagnostics With A StatLab Medical Products Deal
Danaher, through its Leica Biosystems unit, is set to acquire StatLab Medical Products, enhancing its diagnostics and anatomical pathology offerings with more consumables and instruments. This strategic move aims to strengthen Danaher's recurring revenue streams and better positi
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 17 Jul 2026 11:12
- Source
- Market source
Danaher (DHR) Stock Looks Reasonable Despite Rich Earnings Pricing
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jul 2026 07:28
- Source
- simplywall.st
Danaher (DHR) Stock May Trade At A Discount Despite Its 18% Five Year Decline
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 17 Jul 2026 05:09
- Source
- Market source
Form 4 Danaher Corporation For: 16 July By Investing.com
This article reports on a Form 4 filing for Danaher Corporation (DHR) pertaining to activity on July 16, 2026. The brief piece indicates that Danaher's stock (DHR) showed a 2.10% increase. No specific details from the Form 4 filing are provided beyond the date.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 04:37
- Source
- Investing.com Nigeria
Lobbying Update: $36,000 of DANAHER CORPORATION lobbying was just disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 02:22
- Source
- Quiver Quantitative
Can Masimo’s Integration and Bioprocessing Strength Reshape Danaher’s Long-Term Story (DHR)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 02:14
- Source
- Simply Wall St.
Top Research Reports for Interactive Brokers, Danaher & S&P Global
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:39
- Source
- Zacks
Danaher (NYSE: DHR) director Linda Filler exercises 3,298 stock options
Danaher (NYSE: DHR) director Linda Filler exercised 3,298 stock options at an exercise price of $71.88 per share on July 15, 2026. In connection with this, 1,181 shares were disposed of for tax withholding purposes at $200.79 per share. Following these transactions, Filler direct
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:01
- Source
- Stock Titan
Danaher Corp (NYSE: DHR) VP details 60-share stock tax withholding
Danaher Corp's VP and Chief Accounting Officer, Christopher Bouda, reported a tax-withholding disposition of 60 shares of common stock at $200.79 per share to cover tax liabilities. After this transaction, Bouda directly holds 9,107 shares and indirectly holds 679.101 shares thro
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:01
- Source
- Stock Titan
Danaher (NYSE: DHR) director exercises options, 3,298 shares acquired
Danaher director Elias A. Zerhouni exercised options to acquire 3,298 common shares at an exercise price of $71.88, with 1,181 shares subsequently used for tax withholding at $200.79 per share. Following these transactions, Zerhouni directly holds 46,484.282 shares and indirectly
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 20:37
- Source
- Stock Titan
Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 16 Jul 2026 16:10
- Source
- Market source
Danaher Corp. stock outperforms competitors on strong trading day
Danaher Corp. (DHR) stock rose 2.10% to $205.01 on a weak trading day for the broader market, extending its gains for a second consecutive day. The S&P 500 Index (SPX) fell 0.51% and the Dow Jones Industrial Average (DJIA) fell 0.20%, indicating Danaher's strong individual perfor
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 16 Jul 2026 16:35
- Source
- MarketWatch
Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?
Danaher Corporation (DHR) is set to release its Q2 2026 earnings, with analysts projecting a revenue increase of 2.6% to $6.09 billion and earnings per share of $1.84, a 2.2% rise. The company has consistently beaten Zacks Consensus Estimates in the past, and its bioprocessing, c
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 16:07
- Source
- TradingView
Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Danaher (DHR) is projected to report Q2 earnings of $1.84 per share and revenues of $6.09 billion, representing year-over-year increases of 2.2% and 2.6% respectively. Analysts have made slight downward adjustments to the EPS estimate, which can influence investor actions. Beyond
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 16 Jul 2026 13:08
- Source
- Market source
Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics
Leica Biosystems, a subsidiary of Danaher, announced its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity. This deal will integrate StatLab's 50-year histology workflow portfolio with Leica Biosystems' computational pathology platform,
- Tone
- Positive 68/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 11:26
- Source
- Manufacturing Chemist
Liquidity Mapping Around (DHR) Price Events
This article analyzes Danaher Corporation (NYSE: DHR) using AI models to provide trading strategies and multi-timeframe signal analysis. It indicates strong near and mid-term sentiment but a weak long-term outlook, highlighting a significant risk-reward short setup. The analysis
- Tone
- Negative 38/100
- Event
- Guidance
- Published
- 16 Jul 2026 07:07
- Source
- Stock Traders Daily
Danaher stock holds steady as diversified life sciences portfolio underpins long-term growth
Danaher Corp. (ISIN US2358511028) is highlighted as a global life sciences and diagnostics supplier, appealing to long-term investors due to its diversified portfolio and recurring revenue streams. The company's focus on essential laboratory and clinical workflows, alongside stra
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 16 Jul 2026 00:42
- Source
- Ad-hoc-news.de
Danaher’s Leica Biosystems to Acquire StatLab
Danaher's Leica Biosystems is set to acquire StatLab, a privately-held manufacturer of anatomical pathology products. StatLab, with over 50 years of history, offers products for pre-analytical and analytical histology, complementing Leica Biosystems' focus on cancer diagnostics.
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 15 Jul 2026 14:37
- Source
- Medical Product Outsourcing
Danaher stock may move 4.9% on July 21 earnings report By Investing.com
Danaher Corp. (DHR) shares are expected to move 4.9% following its earnings report on July 21, based on options data. The stock has historically surpassed this options-implied movement in three of its last eight earnings announcements. Notably, on October 21, 2025, shares increas
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 10:07
- Source
- Investing.com South Africa
Audax and Linden to sell StatLab Medical Products
Audax Private Equity and Linden Capital Partners are reportedly selling StatLab Medical Products to Leica Biosystems, an operating company of Danaher Corporation. The article, by Iris Dorbian, was published two hours prior to the provided crawl time. Further details about the dea
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 15 Jul 2026 08:08
- Source
- PE Hub
Lab-products maker StatLab set to join Danaher’s Leica
Audax Private Equity and Linden Capital Partners have reached an agreement to sell StatLab Medical Products to Leica Biosystems, an operating company of Danaher Corporation (NYSE: DHR). StatLab, a manufacturer of pre-analytical products for anatomic pathology, expanded globally a
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 14 Jul 2026 21:24
- Source
- Stock Titan
Implied Volatility Surging for Danaher Stock Options
Implied volatility for Danaher Corporation (DHR) stock options is surging, particularly for the Sept. 18, 2026 $140 Call, indicating that the market expects a significant price move. While analysts have slightly reduced current quarter earnings estimates, Danaher remains a Zacks
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 14 Jul 2026 20:07
- Source
- TradingView
Leica Biosystems to Acquire StatLab
Leica Biosystems, a Danaher operating company and leader in precision cancer diagnostics, announced its definitive agreement to acquire StatLab Medical Products. StatLab, previously owned by Linden Capital Partners and Audax Private Equity, is a global developer and manufacturer
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 14 Jul 2026 20:07
- Source
- Market source
Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 Jul 2026 14:00
- Source
- Market source
Danaher (DHR) Gains Attention On FDA Clearance, Is The Stock Fully Priced?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Jul 2026 07:00
- Source
- simplywall.st
Danaher Corp. focuses on life sciences growth as investors watch long-term strategy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- ad-hoc-news.de
Danaher (DHR) Stock Weighs DCF Upside Against Premium P/E After Recent Bounce
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- simplywall.st
Danaher (DHR) Stock Is Up, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source
Why Danaher (DHR) Stock Rose Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Quiver Quantitative